ClinicalTrials.gg
Active, not recruitingNCT07913295Updated Nov 3, 2026

Comparative Effect of Dual Task Training and Rhythmic Stabilization in Knee Osteoarthritis Patients

An interventional study of Dual task training and Rhythmic stabilization in Knee Osteoarthritis, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

Knee osteoarthritis (KOA) is a degenerative joint condition that causes pain, stiffness, reduced proprioception, impaired balance, and decreased physical function. This study aims to compare the effects of Dual Task Training and Rhythmic Stabilization Training on balance, proprioception, and physical function in patients with KOA. A randomized clinical trial will be conducted using convenient sampling, with participants randomly allocated into two groups. Both groups will receive a 15-minute hot pack followed by their respective interventions, three times per week for six weeks,12 sessions.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • knee osteoarthritis
  • dual task training
  • Rhythmic Stabilization
  • balance
  • Pain
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's enrollment of 26 is below the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age 40-60 years Both genders male and female Patient have diagnosed OA severity of (Kellgren Lawrence) Grade I-II knee OA. Patients able to walk independently without assistive device. Knee pain ≥ 3 months. Pain intensity score is 3-6 out of 10 on numeric rating scale. Have unilateral or bilateral knee OA.

Exclusion criteria

Exclusion Criteria:

History of total knee replacement surgery. Inflammatory disorders. Severe visual or hearing impairment.(36) Severe cardiovascular disorders (such as Myocardial infarction) Neurological disorders (e.g., stroke, Parkinson's disease). History of deep vein thrombosis (DVT) and chronic kidney disease. Lower limb fracture.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Dual task training

    Participants will receive dual-task training involving simultaneous performance of motor and cognitive tasks alongside conventional physiotherapy. The intervention will include functional activities such as walking, standing, and sit-to-stand while performing cognitive tasks, including counting backward, verbal fluency, or responding to simple questions. Task difficulty will be progressively increased according to participants' abilities and tolerance to improve balance, functional mobility, and cognitive-motor coordination.

    Other: Dual task training

  • Active comparator
    Rhythmic stabilization

    Participants will receive rhythmic stabilization based on proprioceptive neuromuscular facilitation (PNF) principles, targeting the knee joint in supine, sitting, and standing positions. The technique involves applying alternating manual resistance in multiple directions while participants maintain isometric contractions without allowing joint movement. Participants will be instructed to resist the therapist's forces to facilitate muscle co-contraction, improve knee stability, neuromuscular control, and balance.

    Other: Rhythmic stabilization

Interventions

  • OtherDual task training

    Participants will receive dual-task training involving simultaneous performance of motor and cognitive tasks alongside conventional physiotherapy. The intervention will include functional activities such as walking, standing, and sit-to-stand while performing cognitive tasks, including counting backward, verbal fluency, or responding to simple questions. Task difficulty will be progressively increased according to participants' abilities and tolerance to improve balance, functional mobility, and cognitive-motor coordination. The intervention will be performed three times per week for six weeks.

  • OtherRhythmic stabilization

    Participants will receive rhythmic stabilization based on proprioceptive neuromuscular facilitation (PNF) principles, targeting the knee joint in supine, sitting, and standing positions. The technique involves applying alternating manual resistance in multiple directions while participants maintain isometric contractions without allowing joint movement. Participants will be instructed to resist the therapist's forces to facilitate muscle co-contraction, improve knee stability, neuromuscular control, and balance. The intervention will be performed three times per week for six weeks, alongside conventional physiotherapy.

06

What researchers measure

Primary outcomes

  1. NPRS

    11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADL

    Time frame: Baseline and after 6 weeks

  2. Berg Balance Scale

    The Berg Balance Scale (BBS) will be used to assess functional balance in patients with knee osteoarthritis. It is a standardized 14-item scale that evaluates balance during daily functional activities such as sitting, standing, turning, reaching, transferring, and single-leg standing. Each item is scored on a 4-point Likert scale, with a total score ranging from 0 to 56, where higher scores indicate better balance performance. Scores of 0-20 indicate high fall risk, 21-40 indicate moderate fall risk, and scores ≥41 indicate low fall risk. The BBS is a highly reliable and valid tool for assessing balance in individuals with knee OA

    Time frame: Baseline and after 6 weeks

  3. Joint position Sense Error

    Joint Position Error (JPSE) will be assessed using Smartphone Inclinometer to evaluate proprioception. The participant's limb will be passively positioned at a target angle (e.g., 30° knee flexion) with eyes closed, and then returned to the starting position. The participant will then actively reproduce the same angle, and the smartphone Inclinometer will record the difference between the target and reproduced angle. This difference, measured in degrees, represents the JPSE. Smaller error values indicate better proprioceptive accuracy and joint position sense.

    Time frame: Baseline and after 6 weeks

  4. Western Ontario and McMaster Universities Osteoarthritis Index:

    The WOMAC is a valid, reliable, and widely used disease-specific outcome measure for assessing pain, stiffness, and physical function in individuals with knee osteoarthritis. It comprises 24 items divided into three subscales: pain (5 items), stiffness (2 items), and physical function (17 items). Each item is rated on a 5-point Likert scale ranging from 0 (none) to 4 (extreme). The total score is calculated by summing the responses, with higher scores indicating greater pain, stiffness, and functional impairment

    Time frame: Baseline and after 6 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript

Access criteria: The data can be requested from the corresponding author

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 2 months is below that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 3, 2026
StartActual
Oct 22, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07913295
Lead sponsor
University of Management and Technology Lahore
Responsible party
Rabia Majeed (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Nov 3, 2026
Start date
Oct 22, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion